Cavalletti E - Search Results

1

E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models.

Bello E, Colella G, Scarlato V, Oliva P, Berndt A, Valbusa G, Serra SC, D'Incalci M, Cavalletti E, Giavazzi R, Damia G, Camboni G. Bello E, et al. Among authors: cavalletti e. Cancer Res. 2011 Feb 15;71(4):1396-405. doi: 10.1158/0008-5472.CAN-10-2700. Epub 2011 Jan 6. Cancer Res. 2011. PMID: 21212416

2

The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts.

Bello E, Taraboletti G, Colella G, Zucchetti M, Forestieri D, Licandro SA, Berndt A, Richter P, D'Incalci M, Cavalletti E, Giavazzi R, Camboni G, Damia G. Bello E, et al. Among authors: cavalletti e. Mol Cancer Ther. 2013 Feb;12(2):131-40. doi: 10.1158/1535-7163.MCT-12-0275-T. Epub 2012 Dec 27. Mol Cancer Ther. 2013. PMID: 23270924

3

BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

Manzotti C, Pratesi G, Menta E, Di Domenico R, Cavalletti E, Fiebig HH, Kelland LR, Farrell N, Polizzi D, Supino R, Pezzoni G, Zunino F. Manzotti C, et al. Among authors: cavalletti e. Clin Cancer Res. 2000 Jul;6(7):2626-34. Clin Cancer Res. 2000. PMID: 10914703

4

Outbreaks of hyperkeratotic dermatitis of athymic nude mice in northern Italy.

Scanziani E, Gobbi A, Crippa L, Giusti AM, Giavazzi R, Cavalletti E, Luini M. Scanziani E, et al. Among authors: cavalletti e. Lab Anim. 1997 Jul;31(3):206-11. doi: 10.1258/002367797780596310. Lab Anim. 1997. PMID: 9230500

5

ATP non-competitive Ser/Thr kinase inhibitors as potential anticancer agents.

Cozza G, Bortolato A, Menta E, Cavalletti E, Spinelli S, Moro S. Cozza G, et al. Among authors: cavalletti e. Anticancer Agents Med Chem. 2009 Sep;9(7):778-86. doi: 10.2174/187152009789056930. Anticancer Agents Med Chem. 2009. PMID: 19799530 Review.

6

Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration.

Cavaletti G, Cavalletti E, Oggioni N, Sottani C, Minoia C, D'Incalci M, Zucchetti M, Marmiroli P, Tredici G. Cavaletti G, et al. Among authors: cavalletti e. Neurotoxicology. 2000 Jun;21(3):389-93. Neurotoxicology. 2000. PMID: 10894128

7

Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug.

Zunino F, Pratesi G, Micheloni A, Cavalletti E, Sala F, Tofanetti O. Zunino F, et al. Among authors: cavalletti e. Chem Biol Interact. 1989;70(1-2):89-101. doi: 10.1016/0009-2797(89)90065-3. Chem Biol Interact. 1989. PMID: 2736678

8

Reduced glutathione protects against cisplatin-induced neurotoxicity in rats.

Hamers FP, Brakkee JH, Cavalletti E, Tedeschi M, Marmonti L, Pezzoni G, Neijt JP, Gispen WH. Hamers FP, et al. Among authors: cavalletti e. Cancer Res. 1993 Feb 1;53(3):544-9. Cancer Res. 1993. PMID: 8425186

9

Leptospira interrogans serovar sejroe infection in a group of laboratory dogs.

Scanziani E, Crippa L, Giusti AM, Luini M, Pacciarini ML, Tagliabue S, Cavalletti E. Scanziani E, et al. Among authors: cavalletti e. Lab Anim. 1995 Jul;29(3):300-6. doi: 10.1258/002367795781088261. Lab Anim. 1995. PMID: 7564215

10

Hyperkeratosis-associated coryneform infection in severe combined immunodeficient mice.

Scanziani E, Gobbi A, Crippa L, Giusti AM, Pesenti E, Cavalletti E, Luini M. Scanziani E, et al. Among authors: cavalletti e. Lab Anim. 1998 Jul;32(3):330-6. doi: 10.1258/002367798780559239. Lab Anim. 1998. PMID: 9718482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters